Harwin Peter Evan - Insider Non-Derivative Transactions at Dianthus Therapeutics, Inc. /DE/ (DNTH) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 29, 2023, Harwin Peter Evan's relationship to Dianthus Therapeutics, Inc. /DE/ (DNTH) is Director,TenPercentOwner, and currently has 1,928,503 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other DNTH insiders.
Data Source: SEC.
Harwin Peter Evan - Insider Non-Derivative Transactions of DNTH Common Stock
Harwin Peter Evan - Insider Non-Derivative Transactions at DNTH
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 30, 2023 | P -- (Common Stock) | 24670 | 13.63 | 1928503 |
| Sep 27, 2023 | P -- (Common Stock) | 30000 | 13.15 | 1903833 |